Semazic 0.5 mg/0.375 ml (Injection)

Top Selling Products

Description How to Buy return policy reviews

100% Original Product

Description:

Semazic 0.5 mg/0.375 ml SC Injection contains Semaglutide 0.5 mg per 0.375 ml solution in a pre-filled syringe. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that acts by mimicking the human GLP-1 hormone—stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite.

Uses:

Management of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control.
Reduction of the risk of major adverse cardiovascular events (e.g., stroke, heart attack) in adults with type 2 diabetes and established cardiovascular disease.
Weight management as part of a comprehensive treatment plan under medical supervision.

Dose:

Adults (Maintenance Dose): Typically 0.5 mg injected subcutaneously (SC) once weekly (usually following an initial 4-week initiation period at 0.25 mg weekly).
If additional glycemic control is required after at least 4 weeks on 0.5 mg weekly, the physician may increase the dose to 1 mg once weekly.
Administer subcutaneously into the abdomen, thigh, or upper arm once weekly on the same day each week, strictly as prescribed by a healthcare professional.

No How To Buy Text

No Return Policy Text

Download

Rate this Product

There have been no reviews for this product yet.